Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Lassmann

Showing results (151-160 of 164) with videos related to

Pageof 17
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2015
First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary DiseaseKen Herrmann, Margret Schottelius, Constantin Lapa, et al.
Journal of Nuclear Medicine Technology|June 21, 2014
SNMMI and EANM practice guideline for meckel diverticulum scintigraphy 2.0Stephanie E Spottswood, Thomas Pfluger, Stephen P Bartold, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 6, 2006
Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawalHeribert Hänscheid, Michael Lassmann, Markus Luster, et al.
Frontiers in Aging Neuroscience|September 2, 2014
Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson's diseaseIoannis Ugo Isaias, Jörg Spiegel, Joachim Brumberg, et al.
European Thyroid Journal|June 18, 2025
Predictive factors of radioiodine ablation success: results from a MEDIRAD prospective clinical study for thyroid cancerJan Taprogge, Iain Murray, Hannah Sharman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 22, 2025
Rethinking Dosimetry: A European PerspectiveJohannes Tran-Gia, Francesco Cicone, Michel Koole, et al.
EJNMMI Physics|July 23, 2021
A multicentre and multi-national evaluation of the accuracy of quantitative Lu-177 SPECT/CT imaging performed within the MRTDosimetry projectJohannes Tran-Gia, Ana M Denis-Bacelar, Kelley M Ferreira, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 17, 2015
MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT Applied for Dosimetry of Radiopharmaceutical TherapyMichael Ljungberg, Anna Celler, Mark W Konijnenberg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 24, 2019
EANM procedure guidelines for radionuclide therapy with <sup>177</sup>Lu-labelled PSMA-ligands (<sup>177</sup>Lu-PSMA-RLT)Clemens Kratochwil, Wolfgang Peter Fendler, Matthias Eiber, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|September 5, 2023
ICRP workshop on the review and revision of the system of radiological protection: a focus on research priorities-feedback from the international communityWerner Rühm, Hyungjoon Yu, Christopher Clement, et al.
Pageof 17

Showing results (151-160 of 164) with videos related to

Sort By:
Pageof 17
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2015
First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary DiseaseKen Herrmann, Margret Schottelius, Constantin Lapa, et al.
Journal of Nuclear Medicine Technology|June 21, 2014
SNMMI and EANM practice guideline for meckel diverticulum scintigraphy 2.0Stephanie E Spottswood, Thomas Pfluger, Stephen P Bartold, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 6, 2006
Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawalHeribert Hänscheid, Michael Lassmann, Markus Luster, et al.
Frontiers in Aging Neuroscience|September 2, 2014
Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson's diseaseIoannis Ugo Isaias, Jörg Spiegel, Joachim Brumberg, et al.
European Thyroid Journal|June 18, 2025
Predictive factors of radioiodine ablation success: results from a MEDIRAD prospective clinical study for thyroid cancerJan Taprogge, Iain Murray, Hannah Sharman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 22, 2025
Rethinking Dosimetry: A European PerspectiveJohannes Tran-Gia, Francesco Cicone, Michel Koole, et al.
EJNMMI Physics|July 23, 2021
A multicentre and multi-national evaluation of the accuracy of quantitative Lu-177 SPECT/CT imaging performed within the MRTDosimetry projectJohannes Tran-Gia, Ana M Denis-Bacelar, Kelley M Ferreira, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 17, 2015
MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT Applied for Dosimetry of Radiopharmaceutical TherapyMichael Ljungberg, Anna Celler, Mark W Konijnenberg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 24, 2019
EANM procedure guidelines for radionuclide therapy with <sup>177</sup>Lu-labelled PSMA-ligands (<sup>177</sup>Lu-PSMA-RLT)Clemens Kratochwil, Wolfgang Peter Fendler, Matthias Eiber, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|September 5, 2023
ICRP workshop on the review and revision of the system of radiological protection: a focus on research priorities-feedback from the international communityWerner Rühm, Hyungjoon Yu, Christopher Clement, et al.
Pageof 17